combretastatin has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, Y; Takagi, S | 1 |
| Ahmad, A; Biersack, B; Ficner, R; Mahal, K; Resch, M; Sarkar, FH; Schobert, R; Sethi, S | 1 |
| Chaplin, DJ; Hill, SA; Parkins, CS; Pettit, GR | 1 |
3 other study(ies) available for combretastatin and Experimental Neoplasms
| Article | Year |
|---|---|
Vascular disrupting effect of combretastatin A-4 phosphate with inhibition of vascular endothelial cadherin in canine osteosarcoma-xenografted mice.
Topics: Animals; Antigens, CD; Bibenzyls; Cadherins; Dog Diseases; Dogs; Endothelium, Vascular; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Osteosarcoma | 2019 |
Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells.
Topics: Aniline Compounds; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Survival; Electrophoretic Mobility Shift Assay; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Imidazoles; MAP Kinase Kinase 4; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasms, Experimental; NF-kappa B; Xenograft Model Antitumor Assays | 2015 |
Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Depsipeptides; Flavonoids; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Oligopeptides; Regional Blood Flow; Stilbenes; Tirapazamine; Triazines; Tubulin; Tumor Necrosis Factor-alpha; Vinblastine | 1996 |